Ultrasound Device Shows Promise for Spinal Injuries
A Johns Hopkins proof-of-concept study in animals describes a temporary implant that gives real-time feedback on blood flow and imaging at the injury site.
Updated on Nov. 5, 2026 in Stroke
Johns Hopkins Medicine published a proof-of-concept study in Science Advances describing a temporary ultrasonic spinal cord injury device called MUSIC. The device, the size of a small band-aid, was tested in animals and provided real-time feedback on blood flow and imaging.
Why it matters
An estimated 18,000 spinal cord injuries occur in the United States each year, and the device is designed to give clinicians feedback on the injury site to support decisions during ICU recovery. The work is at the early animal-study stage.
The evidence comes from a first proof-of-concept study in animals, which reports the device was temporarily implanted and provided real-time blood flow and imaging feedback. Whether these results translate to human patients remains unknown.
The players
Johns Hopkins Medicine
The academic medical center that developed the MUSIC device and published the proof-of-concept study.
The details
The device, called the Multimodal Ultrasound System for Injury Care (MUSIC), is placed over the spinal cord at the injury site during surgery and combines diagnostic and therapeutic ultrasound. It received FDA Breakthrough Device Designation in 2023, and the defense department awarded Johns Hopkins Medicine $13.48 million for the research.
Timeline
2023: The device received FDA Breakthrough Device Designation.
November 5, 2026: The proof-of-concept study was published in Science Advances.
Big Picture
The MUSIC device's 2023 FDA Breakthrough Device Designation places it within the agency's expedited pathway for devices addressing serious conditions such as spinal cord injury. The new animal study is early evidence that such designations are being pursued alongside preclinical validation.
For people with spinal cord injuries, this device remains investigational and is not yet available as a treatment option. Any future clinical use would depend on human trials and regulatory review before it could affect treatment decisions.
The takeaway
Early animal work suggests real-time monitoring of the injury site could one day help clinicians during spinal cord injury recovery. Readers should watch for human trial results before drawing conclusions about patient benefit.
What happens next
The research will continue through preclinical studies to optimize the device.
Further reading
Explore more on Stroke to see how neurological injury research is covered across the site.
